カテゴリ： MarketLine, 中国, 企業調査

New China Life Insurance Company Ltd.：企業のM&A・事業提携・投資動向

◆英語タイトル：New China Life Insurance Company Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード：DATA904C1255
◆発行会社（調査会社）：MarketLine
◆発行日：2018年7月
◆ページ数：72
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：中国
◆産業分野：サービス
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD700 ⇒換算￥103,600見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD1,050 ⇒換算￥155,400見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

New China Life Insurance Company Ltd. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s New China Life Insurance Company Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by New China Life Insurance Company Ltd. since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes New China Life Insurance Company Ltd.’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by New China Life Insurance Company Ltd.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on New China Life Insurance Company Ltd.’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by New China Life Insurance Company Ltd. and its subsidiaries since 2007.
- Information about key financial and legal advisors for New China Life Insurance Company Ltd.’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about New China Life Insurance Company Ltd.’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
CORPORATE VENTURING 18
Corporate Venturing – Overview 18
Corporate Venturing – Deal reports 19
CAPITAL RAISING 33
Capital Raising – Deal reports 33
Divestments – Deal reports 52
PRIVATE EQUITY & OWNERSHIP 54
Private Equity and Ownership – Deal reports 54
APPENDIX 62
Contact Us 62
About MarketLine Financial Deals Database 62
Deal Definition and Methodology 64
About MarketLine 71

List of Tables
Table 1: New China Life Insurance Company Ltd. M&A volume and value trend (2014-YTD2018)
Table 2: New China Life Insurance Company Ltd. M&A activity by geography (2014-YTD2018)
Table 3: New China Life Insurance Company Ltd. corporate venturing volume and value trend (2014-YTD2018)
Table 4: New China Life Insurance Company Ltd. corporate venturing by geography (2014-YTD2018)

List of Figures
Figure 1: New China Life Insurance Company Ltd. M&A volume and value trend (2014-YTD2018)
Figure 2: New China Life Insurance Company Ltd. M&A activity by geography (2014-YTD2018)
Figure 3: New China Life Insurance Company Ltd. corporate venturing volume and value trend (2014-YTD2018)
Figure 4: New China Life Insurance Company Ltd. corporate venturing by geography (2014-YTD2018)

★海外企業調査レポート[New China Life Insurance Company Ltd.：企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Energy Recovery Inc (ERII)：企業の財務・戦略的SWOT分析
    Energy Recovery Inc (ERII) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Zayo Group Holdings Inc (ZAYO)：企業の財務・戦略的SWOT分析
    Zayo Group Holdings Inc (ZAYO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • 3i Infotech Ltd (3IINFOTECH)：企業の財務・戦略的SWOT分析
    3i Infotech Ltd (3IINFOTECH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Clark Public Utilities：企業の戦略的SWOT分析
    Clark Public Utilities - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Energy Resources Conservation and Development Commission：企業の戦略的SWOT分析
    Energy Resources Conservation and Development Commission - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key …
  • NovaBay Pharmaceuticals Inc (NBY)-製薬・医療分野：企業M&A・提携分析
    Summary NovaBay Pharmaceuticals Inc (NovaBay), formerly NovaCal Pharmaceuticals Inc is a biopharmaceutical company that develops eyecare products. The company’s products include daily lid and lash hygiene spray solution, skin and wound cleanser, and cosetic procedures. Its daily lid and lash hygiene …
  • Tabuk Pharmaceuticals Manufacturing Company：製薬・医療：M&Aディール及び事業提携情報
    Summary Tabuk Pharmaceuticals Manufacturing Company (Tabuk), a subsidiary of Astra Industrial Group, is a drug company that develops, manufactures and markets branded generic pharmaceuticals and under-licensed products. The company offers products in various therapeutic areas including alimentary tr …
  • Biofrontera AG (B8F)：企業の財務・戦略的SWOT分析
    Biofrontera AG (B8F) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Aquestive Therapeutics Inc (AQST)：製薬・医療：M&Aディール及び事業提携情報
    Summary Aquestive Therapeutics Inc (Aquestive Therapeutics) is a pharmaceutical company that discovers, develops and commercializes prescription drug products and a pipeline of prescription formulations. The company offers PharmFilm a drug delivery platform that delivers existing prescription produc …
  • NORDSEE GmbH.：戦略・SWOT・企業財務分析
    NORDSEE GmbH. - Strategy, SWOT and Corporate Finance Report Summary NORDSEE GmbH. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • KCA Deutag Alpha Ltd：企業の戦略的SWOT分析
    KCA Deutag Alpha Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Pharma Mar SA (PHM)-製薬・医療分野：企業M&A・提携分析
    Summary Pharma Mar SA (Pharma Mar) is a biopharmaceutical company that discovers, develops and markets marine-derived drugs to treat cancer. The company’s marketed product Yondelis (trabectedin), a novel, multimodal, synthetically produced antitumor agent, is indicated for the treatment of advanced …
  • Fidelity Investments Inc：企業の戦略・SWOT・財務情報
    Fidelity Investments Inc - Strategy, SWOT and Corporate Finance Report Summary Fidelity Investments Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Thien Viet Securities Joint Stock Company：企業の戦略的SWOT分析
    Thien Viet Securities Joint Stock Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Cabot Oil & Gas Corp (COG)：企業の財務・戦略的SWOT分析
    Cabot Oil & Gas Corp (COG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Cynosure Inc：医療機器：M&Aディール及び事業提携情報
    Summary Cynosure Inc (Cynosure), a subsidiary of Hologic Inc, is a developer, manufacturer and supplier of light-based aesthetic and medical treatment systems. Its products facilitate non-invasive body contouring, skin revitalization and scar reduction, cellulite reduction, hair removal, gynecologic …
  • Taiwan Cogeneration Corp (8926)：企業の財務・戦略的SWOT分析
    Summary Taiwan Cogeneration Corp (Taiwan Cogeneration) is a power company that offers power and electrical energy generation and cogeneration services. The corporation provides services such as construction, investment, operation, and management of power and energy generation cogeneration plants in …
  • Tel-Instrument Electronics Corp.：企業の戦略・SWOT・財務分析
    Tel-Instrument Electronics Corp. - Strategy, SWOT and Corporate Finance Report Summary Tel-Instrument Electronics Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Unfors RaySafe AB：医療機器：M&Aディール及び事業提携情報
    Summary Unfors RaySafe AB (Unfors), formerly Unfors Instruments AB, is a subsidiary of Fluke Biomedical, medical device company that provides solution for the X-ray room consisting of products which collect radiation. The company’s products include RaySafe ThinX, RaySafe X2, RaySafe Solo, RaySafe Xi …
  • Catalyst Biosciences Inc (CBIO)：企業の財務・戦略的SWOT分析
    Summary Catalyst Biosciences Inc (Catalyst Biosciences), formerly Targacept Inc, is a clinical-stage biopharmaceutical company that develops protease-based advanced medicines to treat hematological indications. The company specializes in hemostasis, with focus on subcutaneous prophylaxis of hemophil …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆